Search Results
Search for other papers by Charles E Massie in
Google Scholar
PubMed
Search for other papers by Inmaculada Spiteri in
Google Scholar
PubMed
Search for other papers by Helen Ross-Adams in
Google Scholar
PubMed
Search for other papers by Hayley Luxton in
Google Scholar
PubMed
Search for other papers by Jonathan Kay in
Google Scholar
PubMed
Search for other papers by Hayley C Whitaker in
Google Scholar
PubMed
Search for other papers by Mark J Dunning in
Google Scholar
PubMed
Cancer Research UK Cambridge Institute, Division of Genetics and Epidemiology, Department of Biological Sciences and School of Medicine, Royal Marsden NHS Foundation Trust, Departments of Pathology, Urology, Surgical Oncology, University of Cambridge, Cambridge, CB2 0RE, UK
Cancer Research UK Cambridge Institute, Division of Genetics and Epidemiology, Department of Biological Sciences and School of Medicine, Royal Marsden NHS Foundation Trust, Departments of Pathology, Urology, Surgical Oncology, University of Cambridge, Cambridge, CB2 0RE, UK
Search for other papers by Alastair D Lamb in
Google Scholar
PubMed
Search for other papers by Antonio Ramos-Montoya in
Google Scholar
PubMed
Search for other papers by Daniel S Brewer in
Google Scholar
PubMed
Cancer Research UK Cambridge Institute, Division of Genetics and Epidemiology, Department of Biological Sciences and School of Medicine, Royal Marsden NHS Foundation Trust, Departments of Pathology, Urology, Surgical Oncology, University of Cambridge, Cambridge, CB2 0RE, UK
Search for other papers by Colin S Cooper in
Google Scholar
PubMed
Cancer Research UK Cambridge Institute, Division of Genetics and Epidemiology, Department of Biological Sciences and School of Medicine, Royal Marsden NHS Foundation Trust, Departments of Pathology, Urology, Surgical Oncology, University of Cambridge, Cambridge, CB2 0RE, UK
Search for other papers by Rosalind Eeles in
Google Scholar
PubMed
Search for other papers by UK Prostate ICGC Group in
Google Scholar
PubMed
Search for other papers by Anne Y Warren in
Google Scholar
PubMed
Search for other papers by Simon Tavaré in
Google Scholar
PubMed
Cancer Research UK Cambridge Institute, Division of Genetics and Epidemiology, Department of Biological Sciences and School of Medicine, Royal Marsden NHS Foundation Trust, Departments of Pathology, Urology, Surgical Oncology, University of Cambridge, Cambridge, CB2 0RE, UK
Cancer Research UK Cambridge Institute, Division of Genetics and Epidemiology, Department of Biological Sciences and School of Medicine, Royal Marsden NHS Foundation Trust, Departments of Pathology, Urology, Surgical Oncology, University of Cambridge, Cambridge, CB2 0RE, UK
Search for other papers by David E Neal in
Google Scholar
PubMed
Search for other papers by Andy G Lynch in
Google Scholar
PubMed
prostate cancer and AR signalling ( Ramos-Montoya et al . 2014 ). Herein, we characterise an epigenetic alteration at the promoter of the related HES5 gene, which has been recently reported in a panel of genes that showed promise as a prostate cancer
Search for other papers by Sisi He in
Google Scholar
PubMed
Search for other papers by Liqian Ma in
Google Scholar
PubMed
Search for other papers by Amy E Baek in
Google Scholar
PubMed
Search for other papers by Anna Vardanyan in
Google Scholar
PubMed
Search for other papers by Varsha Vembar in
Google Scholar
PubMed
Search for other papers by Joy J Chen in
Google Scholar
PubMed
Search for other papers by Adam T Nelson in
Google Scholar
PubMed
Cancer Center at Illinois, University of Illinois at Urbana Champaign, Urbana, Illinois, USA
Search for other papers by Joanna E Burdette in
Google Scholar
PubMed
Cancer Center at Illinois, University of Illinois at Urbana Champaign, Urbana, Illinois, USA
Division of Nutritional Sciences, University of Illinois at Urbana Champaign, Urbana, Illinois, USA
University of Illinois Cancer Center, University of Illinois at Chicago, Chicago, Illinois, USA
Carl R. Woese Institute for Genomic Biology, Anticancer Discovery from Pets to People Theme, University of Illinois at Urbana Champaign, Urbana, Illinois, USA
Search for other papers by Erik R Nelson in
Google Scholar
PubMed
Introduction It is expected that there will be approximately 22,530 new cases of ovarian cancer diagnosed in the USA in 2019, accounting for roughly 2.5% of all female cancers ( American Cancer Society 2019 ). Current therapeutic standard of
Search for other papers by James Yao in
Google Scholar
PubMed
Search for other papers by Abhishek Garg in
Google Scholar
PubMed
Search for other papers by David Chen in
Google Scholar
PubMed
Search for other papers by Jaume Capdevila in
Google Scholar
PubMed
Search for other papers by Paul Engstrom in
Google Scholar
PubMed
Search for other papers by Rodney Pommier in
Google Scholar
PubMed
Search for other papers by Eric Van Cutsem in
Google Scholar
PubMed
Search for other papers by Simron Singh in
Google Scholar
PubMed
Search for other papers by Nicola Fazio in
Google Scholar
PubMed
Search for other papers by Wei He in
Google Scholar
PubMed
Search for other papers by Markus Riester in
Google Scholar
PubMed
Search for other papers by Parul Patel in
Google Scholar
PubMed
Search for other papers by Maurizio Voi in
Google Scholar
PubMed
Search for other papers by Michael Morrissey in
Google Scholar
PubMed
Search for other papers by Marianne Pavel in
Google Scholar
PubMed
Search for other papers by Matthew Helmut Kulke in
Google Scholar
PubMed
Communications 5 3518 . ( https://doi.org/10.1038/ncomms4518 ) 24670920 10.1038/ncomms4518 Frampton GM Fichtenholtz A Otto GA Wang K Downing SR He J Schnall-Levin M White J Sanford EM An P , et al . 2013 Development and validation of a clinical cancer
Search for other papers by Y Capodanno in
Google Scholar
PubMed
Search for other papers by F O Buishand in
Google Scholar
PubMed
Search for other papers by L Y Pang in
Google Scholar
PubMed
Search for other papers by J Kirpensteijn in
Google Scholar
PubMed
Search for other papers by J A Mol in
Google Scholar
PubMed
Search for other papers by D J Argyle in
Google Scholar
PubMed
. The Notch pathway is overexpressed and active in 5-FU-resistant INS cells Analysis of gene expression had revealed that Notch pathway-related receptor, NOTCH2, and its target gene, HES1 were upregulated in both CM and canINS CSC-enriched spheres
Search for other papers by Cristina L Ronchi in
Google Scholar
PubMed
Search for other papers by Silviu Sbiera in
Google Scholar
PubMed
Search for other papers by Barbara Altieri in
Google Scholar
PubMed
Search for other papers by Sonja Steinhauer in
Google Scholar
PubMed
Endocrine and Diabetes Unit, Central Laboratory, Institute of Pathology, Comprehensive Cancer Center Mainfranken, Department of Internal Medicine I, University Hospital, University of Wuerzburg, Oberrduerrbacher-Strasse 6, 97080 Wuerzburg, Germany
Search for other papers by Vanessa Wild in
Google Scholar
PubMed
Search for other papers by Michaela Bekteshi in
Google Scholar
PubMed
Search for other papers by Matthias Kroiss in
Google Scholar
PubMed
Search for other papers by Martin Fassnacht in
Google Scholar
PubMed
Search for other papers by Bruno Allolio in
Google Scholar
PubMed
several target genes, including the hairy enhancer of split ( HES ) family, the HES-related ( HEY ) family, and many others involved in apoptosis ( NFK2 , CDKN1A , BIRC5 /surviving, BCL2 ), cell cycle or proliferation ( CCND1 , DTX1 , p21 / WAF1
Search for other papers by Xi Wei in
Google Scholar
PubMed
Department of Radiotherapy and Oncology, the Second Affiliated Hospital of Soochow University, Suzhou, China
Search for other papers by Shang Cai in
Google Scholar
PubMed
Search for other papers by Rebecca J Boohaker in
Google Scholar
PubMed
Search for other papers by Joshua Fried in
Google Scholar
PubMed
Search for other papers by Ying Li in
Google Scholar
PubMed
Search for other papers by Linfei Hu in
Google Scholar
PubMed
Search for other papers by Yi Pan in
Google Scholar
PubMed
Search for other papers by Ruifen Cheng in
Google Scholar
PubMed
Search for other papers by Sheng Zhang in
Google Scholar
PubMed
Search for other papers by Ye Tian in
Google Scholar
PubMed
Search for other papers by Ming Gao in
Google Scholar
PubMed
Department of Molecular Radiation Oncology, Key Laboratory of Breast Cancer Prevention and Therapy, Ministry of Education, National Clinical Research Center of Cancer, Tianjin Medical University Cancer Institute and Hospital, Tianjin, China
Search for other papers by Bo Xu in
Google Scholar
PubMed
tumor progression and metastasis ( Boohaker & Xu 2014 ). One critical element in the DDR pathway is lysine (K) acetyltransferase 5 (KAT5), which belongs to the MYST family of histone acetyltransferase ( Sun et al . 2010 ). Also known as Tip60, KAT5 is
Search for other papers by Belinda J Petri in
Google Scholar
PubMed
Search for other papers by Kellianne M Piell in
Google Scholar
PubMed
Search for other papers by Ali E Wilt in
Google Scholar
PubMed
Search for other papers by Alexa D Howser in
Google Scholar
PubMed
Search for other papers by Laura Winkler in
Google Scholar
PubMed
Search for other papers by Mattie R Whitworth in
Google Scholar
PubMed
Search for other papers by Bailey L Valdes in
Google Scholar
PubMed
Pathology and Laboratory Medicine, University of Louisville, Louisville, Kentucky, USA
The Brown Cancer Center, University of Louisville, Louisville, Kentucky, USA
Search for other papers by Norman L Lehman in
Google Scholar
PubMed
The Brown Cancer Center, University of Louisville, Louisville, Kentucky, USA
Search for other papers by Brian F Clem in
Google Scholar
PubMed
The Brown Cancer Center, University of Louisville, Louisville, Kentucky, USA
Center for Integrative Environmental Health Sciences (CIEHS), University of Louisville, Louisville, Kentucky, USA
Search for other papers by Carolyn M Klinge in
Google Scholar
PubMed
various cancers, e.g. gastric cancer ( Zhou et al. 2020 ), cervical cancer ( He et al. 2020 ), and ovarian cancer ( Pan et al. 2022 ). Overexpression of miR-145-5p in ovarian cancer cells reduced PSAT1 mRNA ( Pan et al. 2022 ). Cotransfection of
Search for other papers by S Leskelä in
Google Scholar
PubMed
Search for other papers by E Honrado in
Google Scholar
PubMed
Search for other papers by C Montero-Conde in
Google Scholar
PubMed
Search for other papers by I Landa in
Google Scholar
PubMed
Search for other papers by A Cascón in
Google Scholar
PubMed
Search for other papers by R Letón in
Google Scholar
PubMed
Search for other papers by P Talavera in
Google Scholar
PubMed
Search for other papers by J M Cózar in
Google Scholar
PubMed
Search for other papers by A Concha in
Google Scholar
PubMed
Search for other papers by M Robledo in
Google Scholar
PubMed
Search for other papers by C Rodríguez-Antona in
Google Scholar
PubMed
. Hustert E , Haberl M, Burk O, Wolbold R, He YQ, Klein K, Nuessler AC, Neuhaus P, Klattig J, Eiselt R et al. 2001 The genetic determinants of the CYP3A5 polymorphism. Pharmacogenetics 11 773 –779. Kamdem LK , Meineke I
Search for other papers by Lei Gu in
Google Scholar
PubMed
Search for other papers by Paraskevi Vogiatzi in
Google Scholar
PubMed
Search for other papers by Martin Puhr in
Google Scholar
PubMed
Search for other papers by Ayush Dagvadorj in
Google Scholar
PubMed
Search for other papers by Jacqueline Lutz in
Google Scholar
PubMed
Search for other papers by Amy Ryder in
Google Scholar
PubMed
Search for other papers by Sankar Addya in
Google Scholar
PubMed
Cancer Biology, Medicina Sperimentale e Patologia, Biological Sciences, Pharmacy and Experimental Therapeutics, Institute for Pathology, Pathology, Urology, Medical Oncology, Thomas Jefferson University, Philadelphia, Pennsylvania, USA
Search for other papers by Paolo Fortina in
Google Scholar
PubMed
Search for other papers by Carlton Cooper in
Google Scholar
PubMed
Search for other papers by Benjamin Leiby in
Google Scholar
PubMed
Search for other papers by Abhijit Dasgupta in
Google Scholar
PubMed
Search for other papers by Terry Hyslop in
Google Scholar
PubMed
Search for other papers by Lukas Bubendorf in
Google Scholar
PubMed
Search for other papers by Kalle Alanen in
Google Scholar
PubMed
Search for other papers by Tuomas Mirtti in
Google Scholar
PubMed
Cancer Biology, Medicina Sperimentale e Patologia, Biological Sciences, Pharmacy and Experimental Therapeutics, Institute for Pathology, Pathology, Urology, Medical Oncology, Thomas Jefferson University, Philadelphia, Pennsylvania, USA
Cancer Biology, Medicina Sperimentale e Patologia, Biological Sciences, Pharmacy and Experimental Therapeutics, Institute for Pathology, Pathology, Urology, Medical Oncology, Thomas Jefferson University, Philadelphia, Pennsylvania, USA
Search for other papers by Marja T Nevalainen in
Google Scholar
PubMed
prostate cancer will provide a rational basis for the development of effective therapies for advanced prostate cancer. Transcription factor (TF) Stat5 is critical for the growth of human prostate cancer. Stat5 belongs to the Stat gene family ( Ihle 2001
Search for other papers by Marc Lippman in
Google Scholar
PubMed
so much of my career path almost obvious and unavoidable in retrospect. I owe a great deal to my father. He was a remarkably gifted man. Some might say a polymath. He was a fine physician, a scholar, a renowned collector of African tribal art, a